Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Prepaid Assets: 2021-2024

Historic Prepaid Assets for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to $20.1 million.

  • Kiniksa Pharmaceuticals International's Prepaid Assets fell 10.79% to $30.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year decrease of 10.79%. This contributed to the annual value of $20.1 million for FY2024, which is 14.52% up from last year.
  • According to the latest figures from FY2024, Kiniksa Pharmaceuticals International's Prepaid Assets is $20.1 million, which was up 14.52% from $17.5 million recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Prepaid Assets ranged from a high of $20.1 million in FY2024 and a low of $6.6 million during FY2021.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Prepaid Assets had a median value of $17.5 million in 2023 and averaged $16.1 million.
  • Data for Kiniksa Pharmaceuticals International's Prepaid Assets shows a peak YoY soared of 66.44% (in 2023) over the last 5 years.
  • Kiniksa Pharmaceuticals International's Prepaid Assets (Yearly) stood at $6.6 million in 2021, then surged by 60.02% to $10.5 million in 2022, then skyrocketed by 66.44% to $17.5 million in 2023, then grew by 14.52% to $20.1 million in 2024.